the separate financial statements Baht (22.01) million Baht 118.00 million 3. Management Discussion and Analysis 3.1 Sales and service income in 2017 has increased by Baht 526.45 million or 134.09
statements) Baht (74.59) million Baht (5.38) million Profit (loss) for three months (from the separate financial statements) Baht (58.18) million Baht 10.66 million 3. Management Discussion and Analysis 3.1
Profit (Loss) for the year attributable to equity holders of the Company In the consolidated financial statements Baht 418.04 million Baht (202.81) million Profit (loss) for the year in the separate
(from the consolidated financial statements) Baht (27.69) million Baht 41.16 million Profit (loss) for three months (from the separate financial statements) Baht (27.06) million Baht 81.38 million 3
the Company (from the consolidated financial statements) Baht 41.16 million Baht (6.54) million Profit (loss) for three months (from the separate financial statements) Baht 81.38 million Baht 56.64
(from the consolidated financial statements) Baht 313.38 million Baht (74.59) million Profit (loss) for three months (from the separate financial statements) Baht 342.26 million Baht (58.18) million 3
ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate
Medical Business Plc., (CMR) amount Baht 854.83 million. comparing at the same period in 2016 representing 3.30% increase. Income from medical treatments in the separate financial went down 3.46% due to the
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the
Chiang Mai Ram Medical Business Pcl., (CMR) amount Baht 1,035.05 million. comparing at the same period in 2016 representing 11.98% increase. Income from medical treatments in the separate financial went up